Anticholinergic drug use and its association with self-reported symptoms among older persons with and without diabetes

Visa fullständig post



Permalänk

http://hdl.handle.net/10138/313506

Citation

Inkeri , N-M , Karjalainen , M , Haanpaa , M , Kautiainen , H , Saltevo , J , Mantyselka , P & Tiihonen , M 2019 , ' Anticholinergic drug use and its association with self-reported symptoms among older persons with and without diabetes ' , Journal of Clinical Pharmacy and Therapeutics , vol. 44 , no. 2 , pp. 229-235 . https://doi.org/10.1111/jcpt.12772

Titel: Anticholinergic drug use and its association with self-reported symptoms among older persons with and without diabetes
Författare: Inkeri, Niina-Mari; Karjalainen, Merja; Haanpaa, Maija; Kautiainen, Hannu; Saltevo, Juha; Mantyselka, Pekka; Tiihonen, Miia
Upphovmannens organisation: Neurokirurgian yksikkö
Department of Neurosciences
Clinicum
Department of General Practice and Primary Health Care
HUS Neurocenter
Datum: 2019-04
Språk: eng
Sidantal: 7
Tillhör serie: Journal of Clinical Pharmacy and Therapeutics
ISSN: 0269-4727
DOI: https://doi.org/10.1111/jcpt.12772
Permanenta länken (URI): http://hdl.handle.net/10138/313506
Abstrakt: What is known and objective Anticholinergic drug use has been associated with a risk of central and peripheral adverse effects. There is a lack of information on anticholinergic drug use in persons with diabetes. The aim of this study is to investigate anticholinergic drug use and the association between anticholinergic drug use and self-reported symptoms in older community-dwelling persons with and without diabetes. Methods The basic population was comprised of Finnish community-dwelling primary care patients aged 65 and older. Persons with diabetes were identified according to the ICD-10 diagnostic codes from electronic patient records. Two controls adjusted by age and gender were selected for each person with diabetes. This cross-sectional study was based on electronic primary care patient records and a structured health questionnaire. The health questionnaire was returned by 430 (81.6%) persons with diabetes and 654 (73.5%) persons without diabetes. Data on prescribed drugs were obtained from the electronic patient records. Anticholinergic drug use was measured according to the Anticholinergic Risk Scale. The presence and strength of anticholinergic symptoms were asked in the health questionnaire. Results and discussion The prevalence of anticholinergic drug use was 8.9% in the total study cohort. There were no significant differences in anticholinergic drug use between persons with and without diabetes. There was no consistent association between anticholinergic drug use and self-reported symptoms. What is new and conclusion There is no difference in anticholinergic drug use in older community-dwelling persons with and without diabetes. Anticholinergic drug use should be considered individually and monitored carefully.
Subject: anticholinergic burden
anticholinergic drug use
diabetes mellitus
older people
BRAIN-BARRIER PERMEABILITY
ELDERLY-PEOPLE
RISK SCALES
BURDEN
MEDICATIONS
MORTALITY
RESIDENTS
OUTCOMES
317 Pharmacy
3142 Public health care science, environmental and occupational health
Referentgranskad: Ja
Licens: unspecified
Användningsbegränsning: openAccess
Parallelpublicerad version: publishedVersion


Filer under denna titel

Totalt antal nerladdningar: Laddar...

Filer Storlek Format Granska
Anticholinergic_drug_use.pdf 599.9Kb PDF Granska/Öppna

Detta dokument registreras i samling:

Visa fullständig post